STOCK TITAN

Exponent Inc Financials

EXPO
Trailing 12 months to July 3, 2026
Revenue $632.5M +12.8% YoY
Net Income $111.8M +8.7% YoY
EPS (Diluted) $2.23 +12.1% YoY
Free Cash Flow $108.6M -10.2% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 3, 2026 Reported Currency USD FYE January

Exponent Inc (EXPO) reported $632.5M in revenue over the twelve months to Jul 3, 2026, up 12.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EXPO FY2025

A cash-generative business funds substantial shareholder distributions, while receivables and leverage absorb more of the latest growth.

From FY2024 to FY2025, revenue increased 4.2% while operating cash flow decreased 8.9%; the divergence indicates incremental activity converted into cash more slowly. Free cash flow still exceeded net income at $122M versus $106M, but the lower conversion coincided with higher receivables, pointing to working-capital absorption rather than a broad failure of cash generation.

Operating margin slipped from 21.4% to 20.6% in FY2025 even as revenue grew, showing that recent volume did not produce incremental operating leverage. Net margin also fell to 18.2%, while capital expenditures were just $9M; this points to margin pressure rather than a reinvestment burden.

The balance sheet is liquid but becoming more distribution-oriented: current ratio was 2.4x, yet the reported debt-to-equity ratio reached 1.0x as total liabilities climbed and equity declined. Buybacks plus dividends totaled $159M, nearly matching financing outflow of -$160M; shareholder returns explain most of the financing cash use.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 70 / 100
Financial Health Score 70/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Exponent Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
88

Exponent Inc has an operating margin of 20.6%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 88/100, reflecting efficient cost management and pricing power. This is down from 21.4% the prior year.

Growth
46

Exponent Inc's revenue grew a modest 4.2% year-over-year to $582.0M. This slow but positive growth earns a score of 46/100.

Leverage
46

Exponent Inc has a moderate D/E ratio of 0.99. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity
67

With a current ratio of 2.40, Exponent Inc holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 67/100.

Cash Flow
89

Exponent Inc converts 21.0% of revenue into free cash flow ($122.3M). This strong cash generation earns a score of 89/100.

Returns
86

Exponent Inc earns a strong 27.2% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is up from 25.9% the prior year.

Altman Z-Score Safe
8.12

Exponent Inc scores 8.12, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.4B) relative to total liabilities ($387.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/7

Exponent Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.24x

For every $1 of reported earnings, Exponent Inc generates $1.24 in operating cash flow ($131.7M OCF vs $106.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$582.0M
YoY+4.2%
5Y CAGR+7.8%
10Y CAGR+6.4%

Exponent Inc generated $582.0M in revenue in fiscal year 2025. This represents an increase of 4.2% from the prior year.

EBITDA
$129.9M
YoY+0.5%
5Y CAGR+7.6%
10Y CAGR+5.7%

Exponent Inc's EBITDA was $129.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.5% from the prior year.

Net Income
$106.0M
YoY-2.7%
5Y CAGR+5.1%
10Y CAGR+9.3%

Exponent Inc reported $106.0M in net income in fiscal year 2025. This represents a decrease of 2.7% from the prior year.

EPS (Diluted)
$2.07
YoY-1.9%
5Y CAGR+6.0%

Exponent Inc earned $2.07 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$122.3M
YoY-11.1%
5Y CAGR+4.5%
10Y CAGR+8.3%

Exponent Inc generated $122.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 11.1% from the prior year.

Cash & Debt
$221.9M
YoY-14.3%
5Y CAGR+2.4%
10Y CAGR+5.8%

Exponent Inc held $221.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Dividends Per Share
$1.20
YoY+7.1%
5Y CAGR+9.6%

Exponent Inc paid $1.20 per share in dividends in fiscal year 2025. This represents an increase of 7.1% from the prior year.

Shares Outstanding
49M
YoY-3.1%
5Y CAGR-1.0%

Exponent Inc had 49M shares outstanding in fiscal year 2025. This represents a decrease of 3.1% from the prior year.

Margins & Returns

Operating Margin
20.6%
YoY-0.8pp
5Y CAGR-0.2pp
10Y CAGR-1.5pp

Exponent Inc's operating margin was 20.6% in fiscal year 2025, reflecting core business profitability. This is down 0.8 percentage points from the prior year.

Net Margin
18.2%
YoY-1.3pp
5Y CAGR-2.4pp
10Y CAGR+4.3pp

Exponent Inc's net profit margin was 18.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.3 percentage points from the prior year.

Return on Equity
27.2%
YoY+1.3pp
5Y CAGR+4.3pp
10Y CAGR+10.6pp

Exponent Inc's ROE was 27.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks
$97.1M
YoY+1600.4%
5Y CAGR+19.4%
10Y CAGR+15.3%

Exponent Inc spent $97.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1600.4% from the prior year.

Capital Expenditures
$9.4M
YoY+35.3%
5Y CAGR+13.5%
10Y CAGR+5.7%

Exponent Inc invested $9.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 35.3% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

EXPO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EXPO quarterly income statement
MetricQ2'27Q1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25
Revenue$171.6M+3.2%$166.3M+12.8%$147.4M+0.2%$147.1M+3.6%$142.0M-2.4%$145.5M+6.4%$136.8M+0.4%$136.3M
SG&A Expenses$7.4M+19.3%$6.2M-7.6%$6.7M-12.3%$7.7M+24.6%$6.1M+22.7%$5.0M-12.8%$5.7M+8.2%$5.3M
Operating Income$28.0M-32.3%$41.4M+42.0%$29.1M+0.4%$29.0M+69.1%$17.2M-61.3%$44.4M+63.0%$27.3M+5.4%$25.8M
Income Tax$11.4M-11.0%$12.8M+36.7%$9.3M-11.6%$10.6M+3.0%$10.3M-7.6%$11.1M+43.6%$7.7M-21.8%$9.9M
Net Income$29.4M-0.6%$29.6M+19.4%$24.8M-11.7%$28.0M+5.6%$26.6M-0.4%$26.6M+13.0%$23.6M-9.4%$26.0M
EPS (Diluted)$0.60+1.7%$0.59+20.4%$0.49-10.9%$0.55+5.8%$0.520.0%$0.52+15.6%$0.45-10.0%$0.50

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.

EXPO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EXPO quarterly balance sheet
MetricQ2'27Q1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25
Total Assets$652.7M-5.0%$687.4M-11.6%$777.5M+2.1%$761.4M+0.3%$759.4M-0.5%$763.2M-1.8%$777.3M+4.5%$744.1M
Current Assets$312.0M-8.5%$340.9M-20.3%$427.6M+2.6%$416.8M-2.1%$425.7M-1.7%$432.8M-3.2%$446.9M+8.3%$412.6M
Cash & Equivalents$66.6M-43.8%$118.6M-46.6%$221.9M+7.0%$207.4M-10.5%$231.8M-5.4%$245.1M-5.3%$258.9M+17.8%$219.7M
Accounts Receivable$218.5M+10.7%$197.3M+8.7%$181.5M-0.3%$182.0M+6.4%$171.0M+2.5%$166.8M+3.3%$161.4M-4.3%$168.6M
Goodwill$8.6M0.0%$8.6M0.0%$8.6M0.0%$8.6M0.0%$8.6M0.0%$8.6M0.0%$8.6M0.0%$8.6M
Total Liabilities$364.1M+4.3%$349.0M-9.8%$387.2M+8.0%$358.6M+8.1%$331.7M+3.1%$321.8M-9.6%$356.2M+6.7%$333.8M
Current Liabilities$157.8M+11.0%$142.2M-20.1%$178.0M+15.0%$154.8M+14.7%$135.0M+3.6%$130.3M-20.2%$163.2M+18.5%$137.7M
Total Equity$288.6M-14.7%$338.3M-13.3%$390.3M-3.1%$402.9M-5.8%$427.8M-3.1%$441.4M+4.8%$421.1M+2.6%$410.3M
Retained Earnings$696.4M+2.1%$682.0M+2.0%$668.4M+1.5%$658.8M+2.0%$646.0M+1.7%$635.0M+1.7%$624.2M+1.5%$615.0M

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

EXPO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EXPO quarterly cash flow statement
MetricQ2'27Q1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25
Operating Cash Flow$30.9M+3268.1%-$975K-101.8%$55.6M+70.2%$32.7M-9.9%$36.2M+398.0%$7.3M-87.0%$56.1M+88.6%$29.7M
Capital Expenditures$1.8M-27.6%$2.5M-8.7%$2.7M+0.4%$2.7M+17.6%$2.3M+29.6%$1.8M-32.5%$2.6M+51.5%$1.7M
Free Cash Flow$29.1M+949.3%-$3.4M-106.5%$52.9M+76.5%$30.0M-11.7%$33.9M+515.0%$5.5M-89.7%$53.5M+90.9%$28.0M
Investing Cash Flow-$1.8M+27.6%-$2.5M+8.7%-$2.7M-0.4%-$2.7M-17.6%-$2.3M-29.6%-$1.8M+32.5%-$2.6M-51.5%-$1.7M
Financing Cash Flow-$81.2M+18.6%-$99.7M-159.6%-$38.4M+29.5%-$54.5M-14.8%-$47.5M-136.8%-$20.0M-62.7%-$12.3M+4.9%-$13.0M
Dividends Paid$15.0M-9.5%$16.6M+11.4%$14.9M-1.2%$15.1M-1.0%$15.2M-7.0%$16.4M+15.0%$14.2M+0.1%$14.2M
Share Buybacks$67.4M-14.5%$78.8M+223.0%$24.4M-39.1%$40.0MN/AN/A$1K0.0%-$1K

EXPO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EXPO quarterly financial ratios
MetricQ2'27Q1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25
Operating Margin16.3%-8.5pp24.9%+5.1pp19.8%0.0pp19.7%+7.6pp12.1%-18.4pp30.5%+10.6pp19.9%+1.0pp19.0%
Net Margin17.1%-0.7pp17.8%+1.0pp16.8%-2.3pp19.1%+0.4pp18.7%+0.4pp18.3%+1.1pp17.3%-1.9pp19.1%
Return on Equity10.2%+1.4pp8.7%+2.4pp6.3%-0.6pp7.0%+0.7pp6.2%+0.2pp6.0%+0.4pp5.6%-0.8pp6.3%
Return on Assets4.5%+0.2pp4.3%+1.1pp3.2%-0.5pp3.7%+0.2pp3.5%0.0pp3.5%+0.5pp3.0%-0.5pp3.5%
Current Ratio1.98-0.4x2.400.0x2.40-0.3x2.69-0.5x3.15-0.2x3.32+0.6x2.74-0.3x3.00
Debt-to-Equity1.26+0.2x1.030.0x0.99+0.1x0.89+0.1x0.780.0x0.73-0.1x0.850.0x0.81
FCF Margin17.0%+19.0pp-2.1%-37.9pp35.9%+15.5pp20.4%-3.5pp23.9%+20.1pp3.8%-35.3pp39.1%+18.5pp20.5%

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Frequently Asked Questions

What is Exponent Inc's annual revenue?

Exponent Inc (EXPO) reported $582.0M in total revenue for fiscal year 2025. This represents a 4.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Exponent Inc's revenue growing?

Exponent Inc (EXPO) revenue grew by 4.2% year-over-year, from $558.5M to $582.0M in fiscal year 2025.

Is Exponent Inc profitable?

Yes, Exponent Inc (EXPO) reported a net income of $106.0M in fiscal year 2025, with a net profit margin of 18.2%.

Exponent Inc (EXPO) reported diluted earnings per share of $2.07 for fiscal year 2025. This represents a -1.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Exponent Inc (EXPO) had EBITDA of $129.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Exponent Inc (EXPO) had an operating margin of 20.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Exponent Inc (EXPO) had a net profit margin of 18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Exponent Inc (EXPO) paid $1.20 per share in dividends during fiscal year 2025.

Exponent Inc (EXPO) has a return on equity of 27.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Exponent Inc (EXPO) generated $122.3M in free cash flow during fiscal year 2025. This represents a -11.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Exponent Inc (EXPO) generated $131.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Exponent Inc (EXPO) had $777.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Exponent Inc (EXPO) invested $9.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Exponent Inc (EXPO) spent $97.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Exponent Inc (EXPO) had 49M shares outstanding as of fiscal year 2025.

Exponent Inc (EXPO) had a current ratio of 2.40 as of fiscal year 2025, which is generally considered healthy.

Exponent Inc (EXPO) had a debt-to-equity ratio of 0.99 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Exponent Inc (EXPO) had a return on assets of 13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Exponent Inc (EXPO) has an Altman Z-Score of 8.12, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Exponent Inc (EXPO) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Exponent Inc (EXPO) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Exponent Inc (EXPO) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top